Neuromyelitis Optica
RareAutoimmune
Neuromyelitis Optica is treated with 2 medications in our database, including Enspryng, UPLIZNA. 2 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Genentech, Amgen. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Neuromyelitis Optica treatment below.
What help exists for Neuromyelitis Optica
4
drugs indexed
3
with copay cards
3
with patient assistance
9
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Neuromyelitis Optica
4 totalSOLIRIS
ECULIZUMAB Β· Alexion
ππUltomiris
ravulizumab Β· Alexion
ππEnspryng
Satralizumab Β· Genentech
UPLIZNA
Inebilizumab Β· Amgen
ππ
π = copay card Β· π = patient assistance program
Prior authorization patterns for Neuromyelitis Optica drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | Yes | β | β |
β Medicare Part D | β | β | β |
Grants for Neuromyelitis Optica patients
18 total Β· 9 open- open
Amgen Assist 360
Amgen
Covers: financial assistance
- open
Enspryng Co-Pay Program
The Assistance Fund
Covers: financial assistance
- open
PAN Foundation Neuromyelitis Optica Spectrum Disorder Fund
PAN Foundation
Covers: financial assistance
- open
Neuromyelitis Optica Spectrum Disorder Financial Assistance Program
The Assistance Fund
Covers: financial assistance
- open
Amgen SupportPlus Patient Support Program
Amgen
- open
NORD RareCare Patient Assistance Program
National Organization for Rare Disorders, Inc. (NORD)
Covers: financial assistance
- open
Amgen By Your Side Patient Assistance Program: Uplizna
Amgen
Covers: financial assistance
- open
NORD RareCare Patient Assistance Program
National Organization for Rare Disorders, Inc. (NORD)
Covers: financial assistance
- open
PAN Foundation Neuromyelitis Optica Spectrum Disorder Patient Assistance Grant
PAN Foundation
Covers: financial assistance
- unknown
Genentech Transplant Access Services (GTAS)
Genentech
- unknown
Amgen Support Plus
Amgen
- unknown
Genentech Patient Assistance
Genentech
Covers: financial assistance
- unknown
Amgen Assist 360
Amgen
Covers: financial assistance
- unknown
Amgen Support Plus
Amgen
- unknown
Genentech Access to Care
Genentech
- unknown
The Assistance Fund (TAF) Neuromyelitis Optica Spectrum Disorder Fund
The Assistance Fund
Covers: transportation, financial assistance
- unknown
AMGEN Assist
Amgen
Covers: financial assistance
- unknown
Amgen Patient Assistance Program
Amgen
Covers: financial assistance
Neuromyelitis Optica is a rare disease β more resources at UniteRare
Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.
Visit UniteRare β